Publication

Outcomes of rare patients with a primary cutaneous CD30(+) lymphoproliferative disorder developing extracutaneous disease

Melchers, R. C., Willemze, R., Vermaat, J. S. P., Jansen, P. M., Daniels, L. A., Putter, H., Bekkenk, M. W., de Haas, E. R. M., Horvath, B., van Rossum, M. M., Sanders, C. J. G., Veraart, J. C. J. M., Vermeer, M. H. & Quint, K. D., 5-Mar-2020, In : Blood. 135, 10, p. 769-773 6 p.

Research output: Contribution to journalLetterAcademicpeer-review

Copy link to clipboard

Documents

  • Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease

    Final publisher's version, 568 KB, PDF document

    Request copy

DOI

  • Rutger C. Melchers
  • Rein Willemze
  • Joost S. P. Vermaat
  • Patty M. Jansen
  • Laurien A. Daniels
  • Hein Putter
  • Marcel W. Bekkenk
  • Ellen R. M. de Haas
  • Barbara Horvath
  • Michelle M. van Rossum
  • Cornelus J. G. Sanders
  • Joep C. J. M. Veraart
  • Maarten H. Vermeer
  • Koen D. Quint
Original languageEnglish
Pages (from-to)769-773
Number of pages6
JournalBlood
Volume135
Issue number10
Publication statusPublished - 5-Mar-2020

    Keywords

  • LARGE-CELL LYMPHOMA, BRENTUXIMAB VEDOTIN, PAPULOSIS, CLASSIFICATION, GUIDELINES, DIAGNOSIS, EORTC, ISCL

ID: 134371888